Emily Eva Holmes

Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine

Emily Eva Holmes, Maria Jung, Sebastian Meller et al. · PLoS ONE · 2014 · 156 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17

Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition

Dimo Dietrich, Barbara Uhl, Verena Sailer et al. · PLoS ONE · 2013 · 155 citations · Full text

Medicine, Molecular Biology, Pathology +17

<i>PD-L1</i>promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy

Heidrun Gevensleben, Emily Eva Holmes, Diane Goltz et al. · Oncotarget · 2016 · 81 citations · Full text

Medicine, Oncology, Pathology +17

First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial

Moritz Fürstenau, Arnon P. Kater, Sandra Robrecht et al. · The Lancet Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions

Dimo Dietrich, Maria Jung, Svenja Puetzer et al. · PLoS ONE · 2013 · 75 citations · Full text

Medicine, Pathology, Cytopathology +14